Emmaus Life Sciences's total assets for Q3 2025 were $20.76M, a decrease of -11.09% from the previous quarter. EMMA total liabilities were $80.24M for the fiscal quarter, a 1.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.